HOME › DRUGS › RANIBIZUMAB-EQRN
ACTIVE SUBSTANCE / INN

RANIBIZUMAB-EQRN

Brand name(s): CIMERLI
FDA LISTED
PRESCRIPTION
BLA761165
ACTIVE SUBSTANCE
Ranibizumab-Eqrn
REGULATORS
FDA
SPONSORS / MAH
SANDOZ INC
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CIMERLIBLA761165SANDOZ INCPrescription

FULL INTELLIGENCE ON RANIBIZUMAB-EQRN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →